Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
pharmaphorum8h
ACC25: AZ stakes its claim to the oral PCSK9 category
AstraZeneca has revealed phase 2b results with its oral PCSK9 inhibitor AZD0780, including a more than 50% reduction in ...
Verywell Health on MSN4h
A New FDA-Approved Antibiotic May Help Women With Recurring UTIs
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
Alternative version of Ozempic, Wegovy may not be available much longer
Affordable and alternative versions of popular weigh loss drugs, like Ozempic and Wegovy, may no longer be available.
The Lancet23h
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Coronary artery disease has long been understood through the paradigm of epicardial coronary artery obstruction, causing ...